Efficacy and Safety of DLBS2411 in the Management of GERD

Stopped Very low recruitment rate. The Study Site classifies as tertiary referral hospital. Therefore, GERD Patients being referred to the site are mostly those with comorbidities included in the exclusion criteria.

Conditions

• Gastroesophageal Reflux Disease (GERD)

Interventions

• DRUG: Omeprazole
• DRUG: DLBS2411
• DRUG: Placebo capsule of Omeprazole
• DRUG: Placebo caplet of DLBS2411

Sponsor

Dexa Medica Group